Total Payments
$19,926
2024 Payments
$2,030
Companies
60
Transactions
680
Medicare Patients
11,364
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$9,795 (49.2%)
Other$9,075 (45.5%)
Education$1,057 (5.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,795 | 656 | 49.2% |
| Current or prospective ownership or investment interest | $9,075 | 2 | 45.5% |
| Education | $1,057 | 18 | 5.3% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$19,926
676 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $9,075 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $3,069 | 155 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $1,190 | 103 | $0 (2024) |
| ABBVIE INC. | $674.45 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $669.03 | 36 | $0 (2024) |
| PFIZER INC. | $668.38 | 75 | $0 (2024) |
| UROGEN PHARMA, INC. | $298.53 | 15 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $279.39 | 14 | $0 (2021) |
| TOLMAR Pharmaceuticals, Inc. | $264.76 | 15 | $0 (2022) |
| Teleflex LLC | $263.34 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,030 | 134 | Sumitomo Pharma America, Inc. ($597.00) |
| 2023 | $1,732 | 99 | Sumitomo Pharma America, Inc. ($593.32) |
| 2022 | $1,220 | 71 | UROVANT SCIENCES INC ($217.93) |
| 2021 | $1,391 | 72 | Astellas Pharma US Inc ($541.85) |
| 2020 | $1,073 | 59 | Astellas Pharma US Inc ($461.60) |
| 2019 | $1,114 | 80 | Astellas Pharma US Inc ($577.28) |
| 2018 | $1,102 | 76 | Astellas Pharma US Inc ($608.79) |
| 2017 | $10,265 | 89 | Innovative Medical Technologies, LLC ($9,075) |
All Payment Transactions
680 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Urology | ||||||
| 12/10/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $34.82 | General |
| Category: Prostate cancer | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: HORMONE THERAPY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: UROLOGY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: UROLOGY | ||||||
| 11/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: UROLOGY | ||||||
| 11/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Oncology | ||||||
| 11/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 11/04/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.26 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: UROLOGY | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,774 | 3,928 | $923,022 | $215,971 |
| 2022 | 23 | 2,470 | 3,492 | $1.3M | $318,639 |
| 2021 | 24 | 2,620 | 3,549 | $1.0M | $277,886 |
| 2020 | 29 | 3,500 | 5,060 | $1.3M | $342,623 |
Total Patients
11,364
Total Services
16,029
Medicare Billing
$1.2M
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 385 | 631 | $188,892 | $54,008 | 28.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 207 | 245 | $159,423 | $42,879 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 363 | $90,390 | $20,917 | 23.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 16 | 150 | $142,500 | $19,884 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $36,075 | $11,930 | 33.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 82 | 87 | $52,200 | $8,370 | 16.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 13 | 15 | $20,432 | $6,530 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 73 | $8,831 | $4,902 | 55.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 431 | 644 | $28,945 | $4,836 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 74 | 95 | $7,514 | $4,086 | 54.4% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 13 | 13 | $7,150 | $3,658 | 51.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 27 | $10,800 | $3,356 | 31.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 49 | 55 | $8,148 | $3,174 | 39.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 70 | 77 | $19,250 | $3,132 | 16.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $7,275 | $2,726 | 37.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 290 | 375 | $16,875 | $2,673 | 15.8% |
| 52351 | Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | Facility | 2023 | 12 | 12 | $9,455 | $2,561 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 26 | 26 | $5,070 | $2,496 | 49.2% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 11 | 58 | $29,832 | $2,245 | 7.5% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 12 | 12 | $11,750 | $1,853 | 15.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 13 | 13 | $4,160 | $1,849 | 44.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 15 | 16 | $7,137 | $1,500 | 21.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 304 | 484 | $21,595 | $1,063 | 4.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 15 | $2,025 | $780.38 | 38.5% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 14 | 16 | $3,360 | $780.06 | 23.2% |
About Dr. David Brown, MD
Dr. David Brown, MD is a Urology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578536181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Brown, MD has received a total of $19,926 in payments from pharmaceutical and medical device companies, with $2,030 received in 2024. These payments were reported across 680 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($9,795).
As a Medicare-enrolled provider, Brown has provided services to 11,364 Medicare beneficiaries, totaling 16,029 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Westerville, OH
- Active Since 02/13/2006
- Last Updated 05/21/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1578536181
Products in Payments
- GEMTESA (Drug) $1,322
- MYRBETRIQ (Drug) $825.47
- XTANDI (Drug) $632.90
- ERLEADA (Drug) $498.27
- BOTOX (Biological) $426.78
- TOVIAZ (Drug) $410.51
- Myrbetriq (Drug) $390.02
- Xtandi (Drug) $334.43
- ELIGARD (Drug) $321.33
- JELMYTO (Drug) $298.53
- PROVENGE (Drug) $296.85
- ORGOVYX (Drug) $279.42
- Nubeqa (Drug) $215.73
- Axonics (Device) $207.50
- LUPRON DEPOT (Drug) $206.08
- XIAFLEX (Biological) $174.66
- UroLift System (Device) $159.44
- UroLift (Device) $141.65
- VIAGRA (Drug) $134.24
- KEYTRUDA (Biological) $125.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.